292 related articles for article (PubMed ID: 34082769)
1. Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases.
Kim D; Kim KI; Baek SH
J Biomed Sci; 2021 Jun; 28(1):41. PubMed ID: 34082769
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Ambrosio S; Saccà CD; Majello B
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
[TBL] [Abstract][Full Text] [Related]
3. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy.
Chen Y; Jie W; Yan W; Zhou K; Xiao Y
Crit Rev Eukaryot Gene Expr; 2012; 22(1):53-9. PubMed ID: 22339659
[TBL] [Abstract][Full Text] [Related]
6. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
[TBL] [Abstract][Full Text] [Related]
7. The histone LSD1 demethylase in stemness and cancer transcription programs.
Amente S; Lania L; Majello B
Biochim Biophys Acta; 2013 Oct; 1829(10):981-6. PubMed ID: 23684752
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
Hino S; Kohrogi K; Nakao M
Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
10. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
[TBL] [Abstract][Full Text] [Related]
11. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.
Zheng YC; Ma J; Wang Z; Li J; Jiang B; Zhou W; Shi X; Wang X; Zhao W; Liu HM
Med Res Rev; 2015 Sep; 35(5):1032-71. PubMed ID: 25990136
[TBL] [Abstract][Full Text] [Related]
13. HOTAIR lncRNA promotes epithelial-mesenchymal transition by redistributing LSD1 at regulatory chromatin regions.
Jarroux J; Foretek D; Bertrand C; Gabriel M; Szachnowski U; Saci Z; Guo S; Londoño-Vallejo A; Pinskaya M; Morillon A
EMBO Rep; 2021 Jul; 22(7):e50193. PubMed ID: 33960111
[TBL] [Abstract][Full Text] [Related]
14. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
Luo H; Shenoy AK; Li X; Jin Y; Jin L; Cai Q; Tang M; Liu Y; Chen H; Reisman D; Wu L; Seto E; Qiu Y; Dou Y; Casero RA; Lu J
Cell Rep; 2016 Jun; 15(12):2665-78. PubMed ID: 27292636
[TBL] [Abstract][Full Text] [Related]
15. Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.
Lian SX; Shao YB; Liu HB; He JY; Lu WQ; Zhang Y; Jiang Y; Zhu J
Oncotarget; 2015 Oct; 6(32):33065-76. PubMed ID: 26460616
[TBL] [Abstract][Full Text] [Related]
16. E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cells.
Zhang Y; Wu T; Zhao B; Liu Z; Qian R; Zhang J; Shi Y; Wan Y; Li Z; Hu X
Cancer Sci; 2022 Feb; 113(2):489-499. PubMed ID: 34839571
[TBL] [Abstract][Full Text] [Related]
17. Histone Demethylase LSD1 Promotes Adipocyte Differentiation through Repressing Wnt Signaling.
Chen Y; Kim J; Zhang R; Yang X; Zhang Y; Fang J; Chen Z; Teng L; Chen X; Ge H; Atadja P; Li E; Chen T; Qi W
Cell Chem Biol; 2016 Oct; 23(10):1228-1240. PubMed ID: 27642069
[TBL] [Abstract][Full Text] [Related]
18. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.
Gong Z; Li A; Ding J; Li Q; Zhang L; Li Y; Meng Z; Chen F; Huang J; Zhou D; Hu R; Ye J; Liu W; You H
Adv Sci (Weinh); 2021 Aug; 8(15):e2004504. PubMed ID: 34050636
[TBL] [Abstract][Full Text] [Related]
19. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
20. LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter.
Liu Y; Wang Y; Chen C; Zhang J; Qian W; Dong Y; Liu Z; Zhang X; Wang X; Zhang Z; Shi X; Wu S
Oncotarget; 2017 Feb; 8(7):11329-11342. PubMed ID: 27894088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
